Deoxycytidine + thymidine
Deoxycytidine + thymidine has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Aug 13, 2021: “Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency”.
- 1 lab in 1 country
- Funders: Eunice Kennedy Shriver National Institute of Child Health and Human Development and 3 more
- Animals1
What did studies of Deoxycytidine + thymidine find?
2Studies of Deoxycytidine + thymidine measured 2 outcomes; the most studied are mitochondrial DNA copy number (1 study) and lifespan (1).
Mitochondrial DNA copy number
upin mice1
1 study
Mitochondrial DNA copy number
upin mice1
Deoxycytidine + thymidine increases mitochondrial DNA copy number in mice.
“addition of deoxycytidine and deoxythymidine supplementation to AAV9 + AAV2 treated Tk2KI mice dramatically improved mtDNA copy numbers in the liver and kidneys”
Animalsin AAV9 + AAV2 treated Tk2KI miceliver and kidneys
Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency
Annals of neurology
Lifespan
upin mice1
1 study
Lifespan
upin mice1
Deoxycytidine + thymidine extends lifespan in mice.
“Furthermore, addition of deoxycytidine and deoxythymidine supplementation to AAV9 + AAV2 treated Tk2KI mice dramatically improved mtDNA copy numbers in the liver and kidneys, animal growth, and lifespan.”
Animalsin AAV9 + AAV2 treated Tk2KI mice
Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency
Annals of neurology